BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 422102)

  • 1. [Therapy for poisonings--antidote. 3. Antidote indications B-E].
    Daunderer M
    Fortschr Med; 1979 Jan; 97(3):99-102. PubMed ID: 422102
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antidote therapy in poisonings].
    Velvart J; Nisoli A
    Ther Umsch; 1986 Apr; 43(4):250-8. PubMed ID: 3715766
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxicology: pearls and pitfalls in the use of antidotes.
    Smollin CG
    Emerg Med Clin North Am; 2010 Feb; 28(1):149-61, ix. PubMed ID: 19945604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The possibilities for the antidote therapy of acute poisonings].
    Bogoiavlenskiĭ VF; Bogoiavlenskiĭ IF
    Med Sestra; 1991 Oct; 50(10):54-8. PubMed ID: 1803200
    [No Abstract]   [Full Text] [Related]  

  • 5. Current views on antidotal therapy in managing cases of poisoning and overdose.
    Pillay VV
    J Assoc Physicians India; 2008 Nov; 56():881-92. PubMed ID: 19263688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy for poisonings antidotes. Antidote indications L-Z].
    Daunderer M
    Fortschr Med; 1979 Feb; 97(5):198-203. PubMed ID: 428858
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy for poisonings--antidotes. 4. Antidote indications F-K].
    Daunderer M
    Fortschr Med; 1979 Jan; 97(4):139-40. PubMed ID: 422104
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy for poisonings--antidotes. 1. The ABC of poisoning treatment, antidotes (indications, dosage)].
    Daunderer M
    Fortschr Med; 1978 Jul; 96(25):1313-7. PubMed ID: 669522
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy in poisonings--antidote 7: The antidotes physostigmine salicylate, toluidin blue].
    Daunderer M
    Fortschr Med; 1980 Feb; 98(7):245-8. PubMed ID: 7364382
    [No Abstract]   [Full Text] [Related]  

  • 10. Antidote use in the critically ill poisoned patient.
    Betten DP; Vohra RB; Cook MD; Matteucci MJ; Clark RF
    J Intensive Care Med; 2006; 21(5):255-77. PubMed ID: 16946442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of poisoning--antidote. 8. Ingestion of caustics, poison gas, gas poisoning, narcotics poisoning].
    Daunderer M
    Fortschr Med; 1980 Apr; 98(16):612-5. PubMed ID: 7390375
    [No Abstract]   [Full Text] [Related]  

  • 12. Old antidotes, new antidotes, and a 'universal antidote': what should we be using for pediatric poisoning?
    Liebelt EL
    Curr Opin Pediatr; 2007 Apr; 19(2):199-200. PubMed ID: 17496765
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute poisoning. 4: Antidote therapy].
    Horn J
    Fortschr Med; 1995 Apr; 113(12):178-80. PubMed ID: 7789933
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antidote therapy for cyanide poisoning].
    Boiarintsev VV; Grebeniuk AN; Minaev DIu; Nazarov VB
    Voen Med Zh; 2008 May; 329(5):16-9. PubMed ID: 18589697
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antidote use in a pediatric emergency department].
    Martínez Sánchez L; Almario Hernández AF; Escuredo Argullós L; Maçao P; Trenchs Sainz de la Maza V; Luaces Cubells C
    An Pediatr (Barc); 2014 Oct; 81(4):220-5. PubMed ID: 24439102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common reversal agents/antidotes in small animal poisoning.
    Khan SA
    Vet Clin North Am Small Anim Pract; 2012 Mar; 42(2):403-6, ix. PubMed ID: 22381188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physostigmine: is there a role for this antidote in pediatric poisonings?
    Frascogna N
    Curr Opin Pediatr; 2007 Apr; 19(2):201-5. PubMed ID: 17496766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of new and established antidotes.
    Bolgiano EB; Barish RA
    Emerg Med Clin North Am; 1994 May; 12(2):317-34. PubMed ID: 8187686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative efficacy of antidotes: the IPCS evaluation series. International Programme on Chemical Safety.
    Jacobsen D; Haines JA
    Arch Toxicol Suppl; 1997; 19():305-10. PubMed ID: 9079217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and institutional aspects of antidote therapy in Russia.
    Ostapenko YN; Luzhnikov EA; Nechiporenko SP; Petrov AN
    Przegl Lek; 2001; 58(4):290-2. PubMed ID: 11450355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.